Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

quant Business Cycle Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

quant Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund housequantHDFC
NAV₹16.2005₹22.8170
NAV date20 Nov 202620 Nov 2026
History3.5 years3.1 years
Expense ratio2.8%2.1%
Stars★★★★★★★★★★
Growth Score11.4093.90

Returns

quant Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+3.68%+12.87%
3 months−0.74%+6.85%
6 months+1.06%+17.20%
YTD+3.68%+32.43%
1 year+0.82%+30.73%
3 years (CAGR)+7.98%+29.16%
5 years (CAGR)——
10 years (CAGR)——
Since launch+14.85%+30.28%

Risk

quant Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility20.0%15.8%
Downside volatility13.8%8.6%
Sharpe0.071.44
Sortino0.112.64
Calmar0.261.94
Return / risk0.401.85
Deepest fall−30.87%−15.07%
Days to recover—133
Below its high−16.59%+0.00%

Against benchmark

quant Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha−3.89%+6.36%
Beta1.100.97
R²78.3%85.0%
Up capture101.2%106.7%
Down capture127.0%74.4%
Tracking error9.5%6.1%
Information ratio−0.350.97
Treynor0.000.22

Consistency

quant Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+71.76%+64.96%
Middle 1-year+1.78%+21.84%
Worst 1-year−20.94%+0.52%
1-year periods with a loss41.8%0.0%
Middle 3-year+12.95%+28.68%
Positive months61.1%69.4%
Best day+4.52%+3.19%
Worst day−7.80%−3.62%
Worst 5% day−1.82%−1.50%
Positive days54.9%58.1%
NAVs a year247247

SIP of ₹10,000 a month

quant Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR+1.89%+26.26%
1-year XIRR+5.86%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth